×

Drug costs hit insurers: Gilead still a buy?

12:15 PM ET Fri, 25 July 2014

CNBC's Bertha Coombs reports which insurance stocks are feeling the pressure from high drug costs. FMHR trader Stephen Weiss advises investors to stick with Gilead.